Zacks Market Edge Highlights: United Technologies, Norfolk Southern, Arista Networks, Fortescue Metals And Shin-Etsu Chemical

For Immediate Release

Chicago, IL – April 11, 2019 – Zacks Market Edge is a podcast hosted weekly by cks Stock Strategist Tracey Ryniec. Every week, Tracey will be joined by guests to discuss the hottest investing topics in stocks, bonds and ETFs and how it impacts your life. To listen to the podcast, click here:

(Please use the Soundcloud link from this URL for the PR. Thanks: https://www.zacks.com/stock/news/377815/stocks-to-combat-recession-worries )

Stocks to Combat Recession Worries

Welcome to Episode #172 of the Zacks Market Edge Podcast.

Every week, host and Zacks stock strategist, Tracey Ryniec, will be joined by guests to discuss the hottest investing topics in stocks, bonds and ETFs and how it impacts your life.

In this episode, Tracey is joined by Zacks Chief Equity Strategist, John Blank, to talk about their favorite topic: is the US economy in a recession?

And if so, how do you invest for it?

Tracey and John first covered this subject all the way back in Episode #20 of the podcast, in February 2016, which was titled “Why There Won’t Be a Recession in 2016.”

And, actually, there wasn’t.

Signs of a Recession

But it’s worth looking, again, at what is one of the most important indicators of a recession: employment.

For the week ending March 30, the jobless claims fell 10,000 to 202,000, which was back to a 49-year low.

The March employment report also showed unemployment unchanged at 3.8%.

Additionally, Bank of America (NYSE:BAC) announced that it was raising its minimum wage to $17, with it rising to $20 an hour, by 2021.

That’s a sign that the job market remains tight. Companies don’t raise wages to be nice.

Conclusion?

The United States isn’t in a recession.

So why is everyone so nervous about one?

Stocks for a Recession

It doesn’t hurt for investors to be prepared as a recession is, ultimately, inevitable.

1. United Technologies (NYSE:UTX) is planning on splitting into three companies by 2020 with Otis and Carrier being separated during that time. In the meantime, the shares are underperforming the S&P 500 and a have a forward P/E of 16.9.

2. Norfolk Southern (NYSE:NSC) is busting out to 5-year highs but earnings are expected to be up 9.3% in 2019 and another 14.7% in 2020 for this railroad. The rails may be old school but investors have been cashing in.

3. Arista Networks (NYSE:ANET) which provides software driven cloud networking, has been a big momentum stock in 2019. Shares are up 51% year-to-date. It’s not cheap, with a forward P/E of 34, but you’re buying the growth story.

Get The News You Want

Read market moving news with a personalized feed of stocks you care about.

Get The App

4. Fortescue Metals Group (OTC:FSUGY) is an Australian iron ore company. It’s trading at just 11.6x earnings even though shares have soared 96% year-to-date. As China’s growth ramps back up, the Australian commodity plays should benefit.

5. Shin-Etsu Chemical (OTC:SHECY) is the 9^th largest chemical company in Japan. One of its specialties is chip chemicals. Shares are up 21% year-to-date.

What else should you know about investing for a possible recession?

Tune into this week’s podcast to find out.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

Follow us on Twitter: https://twitter.com/zacksresearch

Join us on Facebook (NASDAQ:FB): https://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com

https://www.zacks.com/performance

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit Zacks Investment Research

Written By: Zacks Investment Research